Summary: This study aimed to detect the protein expression of HA117 in pediatric solid tumors. Immunohistochemistry was performed to detect the expression of HA117 and P-gp in pediatric solid tumors. In Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), nephroblastoma (WT), and neuroblastoma (NB), the positive expression rate of HA117 was 65.4%, 58.3%, 81.3%, and 74.1%, and that of P-gp was 57.7%, 70.8%, 65.6%, and 66.7%, respectively. HA117 expression was closely related to the clinical stage of HL (P = 0.004) and to the International Prognostic Index score, mediastinal lesions, and clinical stages of NHL (P = 0.01, 0.03, and 0.01). The expression of HA117 in WT was higher than in adjacent normal tissues, but there was no statistical significance (P = 0.21). The positive expression of HA117 in NB was markedly higher than that in normal tissues (P = 0.002), which closely associated with histologic type and lymph node metastasis (P = 0.03 and 0.001). Spearman correlation analysis revealed that HA117 expression was not correlated with P-gp in these 4 tumors. This suggests that HA117 might be an important resistance gene in pediatric solid tumors. The mechanism underlying the resistance to all-trans retinoic acid conferred by HA117 is different from that of P-gp.
H odgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), nephroblastoma (WT), and neuroblastoma (NB) are common solid tumors in children. HL and NHL account for 15% to 20% of malignancies in children. The incidence of NB and WT is about 7% and 5%, respectively, in children. 1 All-trans retinoic acid (ATRA) is a major drug used for the treatment of leukemia and is also an important drug for some solid tumors. However, multidrug resistance (MDR) to ATRA usually affects therapeutic efficacy during the treatment of malignancies. Besides the close relationship between high P-gp expression and resistance to chemotherapy, other genes have been shown to be associated with drug resistance.
In our previous studies, an MDR cell line (HL-60/ ATRA) was induced with ATRA. Suppression subtractive hybridization, microarray assays, and sequence homology analysis were used to screen drug resistance-related genes. 2 A novel ATRA-related MDR gene HA117 was identified (GenBank No: AY230154). Previous studies revealed that HA117 is involved in MDR of solid tumors in adults, but its role has not been reported in children tumors. This study aimed to elucidate the characteristics of HA117 and P-gp expression in these solid tumors from children and explore the mechanism of drug resistance. University. There were 23 males and 3 females among the 26 children with HL, with a median age of 6 years (range, 2 to 15 y). Lactate dehydrogenase r220 mmol/L was found in 9 children and lactate dehydrogenase >220 mmol/L was found in 15 children; 2 patients were not detected. Among the 24 children with NHL, there were 18 males and 6 females with a median age of 5.4 years (range, 2 to 14 y), and all patients had aggressive NHL. Among the 32 children with WT, there were 15 males and 17 females with a median age of 4.5 years (range, 5 mo to 9 y). Among the 27 children with NB, there were 17 males and 10 females with a median age of 2.7 years (range, 4 mo to 5 y). Integrated the differentiation degree of tumor cells, mitotic index and age, the NB is divided into good prognosis type (FH) and poor prognosis type (UH). NB of FH was found in 12 children and that of UH in 11; 4 patients were not given histologic type. Other clinical characteristics are shown in Tables 4-6 .
MATERIALS AND METHODS

Subjects
Reagents
The HA117 polyclonal antibody (our laboratory), MDR1 monoclonal antibody (Biolegend, San Diego, CA), immediate Elivision Super Kit for immunohistochemistry (Maixin-Bio, Fuzhou, China), and a DAB kit (Zhongshan Golden Bridge Biotech, Beijing, China) were used in the present study.
METHODS
Tissues were fixed in 10% neutral formalin, dehydrated, embedded in paraffin, and cut into 4-mm sections. Immunohistochemistry was performed using the streptavidin-peroxidase method to detect the protein expression of HA117 and P-gp. For HL and NHL, the primary antibody was replaced with phosphate-buffered saline in the negative control; for WT and NB, normal tissues 2 cm away from the tumor served as controls. Tissues were incubated overnight at 41C with HA117 (1:100) and P-gp antibody (1:200).
Determination
Semiquantitative analysis was used to evaluate the expression of HA117 and P-gp. 
Statistical Analysis
Statistical analysis was performed using SPSS version 17.0 for Windows (SPSS, Chicago, IL). Comparisons of rates were done using the Fisher exact test. Spearman correlation analysis was used to analyze the relationship between 2 variables. A value of P < 0.05 was considered statistically significant.
RESULTS
Comparison of HA117 and P-gp Expression in HL, NHL, WT, and NB HA117 was strongly positive in all pediatric solid tumors. In HL, NHL, WT, and NB, the positive expression rate of HA117 was 65.4%, 58.3%, 81.3%, and 74.1%, and that of P-gp was 57.7%, 70.8%, 65.6%, and 66.7%, respectively. HA117 and P-gp in HL and NHL was mainly expressed in the cell cytoplasm and membrane (Figs. 1A-H); Table 1 ). HA117 and P-gp in WT and the adjacent normal tissues were mainly expressed in the renal tubules and the cytoplasm of vascular endothelial cells, but they were not observed in the glomeruli (Figs. 1J-M); Table 2 ). The expression of HA117 and P-gp in NB was shown in Figure 1N -Q and Table 3 .
HA117 Expression and Clinical Characteristics of Solid Tumors
Expression of HA117 in stage III and IV was markedly higher than that in stage I and II in HL (P = 0.01). In NHL, HA117 expression was significantly correlated with the International Prognostic Index score, mediastinal lesions, and clinical stage ( Table 4) .
Expression of HA117 in WT was not associated with sex, histologic type, clinical stage, lymph node metastasis, or chemotherapy before surgery (Table 5) .
Expression of HA117 in NB with lymph node metastasis and in NB of UH was markedly higher than that in NB without lymph node metastasis and in NB of FH, respectively (P = 0.001 and 0.03) ( Table 6 ).
Correlation of HA117 and P-gp Expression in Different Solid Tumors
In the present study, the correlation between HA117 and P-gp expression was evaluated in different solid tumors. Spearman correlation analysis showed that there was no correlation between HA117 and P-gp expression in HL (r 1 = 0.02, P 1 = 0.73), NHL (r 2 = 0.26, P 2 = 0.52), WT (r 3 = 0.12, P 3 = 0.27), or NB (r 4 = 0.09, P 4 = 0.75).
DISCUSSION
Retinoic acid is a useful agent in the treatment of leukemia and some solid tumors. Studies on mantle cell lymphoma, 3 B-cell NHLs, 4 W13 cells (a cell line derived from a blastemal Wilms tumor), [5] [6] [7] and NB cells [8] [9] [10] had approved that ATRA was able to inhibit proliferation, induce differentiation and apoptotic, or change cellular morphology. And even, ATRA had been used in clinical trials in children with advanced NB. 11 However, it is frequently observed the clinical resistance to ATRA induction therapy.
The drug resistance of some solid tumors, such as NB, 12-14 NHL, 15, 16 and WT, 17, 18 is related to lung 20 showed that ATRA resistance in part related to P-gp expression in HL60 cells. However, Takeshita et al 21 showed that P-gpassociated MDR and ATRA-resistance seems to exist independently in NB4 cells.
HA117, a novel ATRA-related resistance gene, is an important addition to the resistance gene spectrum. In our previous studies, drug resistance was investigated in a human Burkitt lymphoma cell line (Raji cells), K562 cells, and Junkat cells, which were transfected with the HA117 gene. 22 At the same time, the expression of HA117 was detected in solid tumors of adults, including colon adenocarcinoma, 23 lung cancer, 24 and breast cancer. 24 Our findings showed that HA117 is involved in drug resistance of these tumors, especially in tumors of the lymphatic system and poorly differentiated tumors.
In the present study, our results showed high expression of HA117 in HL, NHL, WT, and NB. These observations suggested that drug resistance of solid tumors in children is not only related to MDR1 but also to HA117. This showed that the importance of HA117 in the solid tumors of children.
Clinical stage and resistance to chemotherapy are positively correlated with the expression of resistancerelated genes, which is an important factor for evaluating prognosis. Our results showed that HA117 expression in stage III and IV HL in children was higher than that in stage I and II. In addition, the International Prognostic Index score, mediastinal lesions, and clinical stage of NHL were significantly correlated with HA117 expression. This suggested that HA117 expression may be an important predictor of prognosis of HL and NHL.
Our results showed that HA117 expression in WT and its adjacent normal tissues was similar (P = 0.21). However, HA117 expression in NB was markedly higher than that in the adjacent normal tissues (P = 0.002). This suggested that the kidney is one of the organs with high HA117 expression, 25 and further demonstrates that HA117 expression is tissue-specific.
In 32 children with WT, HA117 expression was not related to sex, histologic type, clinical stage, lymph node metastasis, or preoperative chemotherapy. This, together with the positive expression rate of HA117 in WT and adjacent normal tissues, suggested that HA117 is expressed in normal kidney tissues and its expression might be higher in the fetal kidney.
In the present study, HA117 expression was markedly increased in NB from patients with lymph node metastasis and patients with NB of UH. The expression of HA117 is associated with the malignant type. HA117 expression can be used to determine the type of malignancy and might be applied to predict the prognosis of NB. Clinically, patients of metastasis and patients of UH usually have poor sensitivity to chemotherapy, which may be attributed to the drug resistance of NB. Thus, selection of chemotherapeutics is crucial in the clinical treatment of NB.
In ATRA-induced NB differentiation, 8, 26, 27 resistance to cytotoxic drugs might be attributed to the high expression of bcl-2, 28 because bcl-2 can inhibit apoptosis, leading to drug resistance. Ramachandran et al 29 found that the expression of MDR1 and lung resistance related protein in drug resistant WT of children was related to reduced apoptosis of cancer cells. In our previous study, our results showed that the HA117 gene encoded a basic protein composed of 365 amino acids. This protein has 4 functional sites related to protein kinase phosphorylation, and its functional domain has homology with the PYRIN domain, an important motif controlling apoptosis. 30, 31 Thus, we speculate that HA117 may induce drug resistance by reducing apoptosis of cancer cells.
In addition, we evaluated the correlation between P-gp and HA117 expression in HL, NHL, WT, and NB of children. Spearman correlation analysis showed that P-gp expression was not associated with HA117 expression. This, together with the positive expression rate of HA117 and P-gp and the location of HA117 and P-gp expression, suggested that the HA117 protein is an important drug resistance-related protein in addition to P-gp and further confirms that the mechanism underlying HA117-induced drug resistance is different from that due to MDR1 gene.
CONCLUSIONS
HA117 is highly expressed in HL, NHL, WT, and NB, and its expression may be used to evaluate drug resistance and guide the selection of chemotherapeutics for these solid tumors, which could minimize irrational treatment and improve therapeutic efficacy. In addition, in our observations, the positive expression rate of HA117 in HL, WT, and NB is higher than that of P-gp, which suggests that the novel HA117 gene perhaps play an important role in guiding clinical treatment and predicting prognosis, and it seems to be used as an indicator distinct from P-gp. But the specific resistance mechanism of HA117 remains to be further studied. 
